The most notable result of our study was the evidence that IFN-β expression was, depending on cell type, 40–65% lower in lung cells from stable COPD patients, indicating a possible impairment in their local immune response. The gene discussed is IFNB1; the disease is chronic obstructive pulmonary disease.